Unichem-Labs. Stock/Share Prices, Buy and Sell Unichem-Labs. NSE Stocks

Unichem Laboratories Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

19 Sep 2018 | 04:14 PM

213.45

-6.80 (-3.09%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-14.76%

Return (1Y)

Underperformed Nifty 500 by 21.39%
More Volatile

2.19%

Standard Deviation (1Y)

Higher than Nifty 500 by 1.48%
Inconsistent Performer

3/12

Months

underperformed Nifty 500
AxisDirect View

No View

52 Week High-Low

382

212

News & Announcements

Unichem Laboratories CFO retires
17 days ago

Unichem Laboratories CFO retires

03 - Sep - 2018 12:00 AM | 17 days ago

Unichem Laboratories announced that Rakesh Parikh, Chief financial officer (CFO) has retired from the services of the Company on 31 August 2018, on attaining the age of superannuation. Consequently he has ceased to be the CFO of the Company.
Powered by Capital Market - Live News
Unichem Laboratories allots 6075 equity shares
54 days ago

Unichem Laboratories allots 6075 equity shares

28 - Jul - 2018 12:00 AM | 54 days ago

Unichem Laboratories has allotted 6,075 equity shares having a face value of Rs. 2/- each, pursuant to exercise of options under the Employees Stock Option Scheme, 2008.
Powered by Capital Market - Live News
Unichem Laboratories to hold board meeting
70 days ago

Unichem Laboratories to hold board meeting

12 - Jul - 2018 12:00 AM | 70 days ago

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 28 July 2018, to consider and approve the unaudited financial results for the period ended Jun 30, 2018
Powered by Capital Market - Live News
Unichem Laboratories received final ANDA approval for Montelukast Chewable Tablets
78 days ago

Unichem Laboratories received final ANDA approval for Montelukast Chewable Tablets

04 - Jul - 2018 12:00 AM | 78 days ago

Unichem Laboratories has received final ANDA approval for its Montelukast Chewable Tablets, 4 mg and 5 mg from the USFDA to market a generic version of Merck Sharp & Dohme Corporation's Singulair Tablets, 4 mg and 5 mg.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Unichem Laboratories Ltd is trading very close to its 52 Week Low
FII shareholding in Unichem Laboratories Ltd has increased by 3.99% since past 3 Months
MF shareholding in Unichem Laboratories Ltd has decreased by -3.75% since past 3 Months
FII shareholding in Unichem Laboratories Ltd has increased by 28.88% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Unichem Laboratories Ltd NSE / BSE Pharmaceuticals, Mid Cap

213.45 -6.80 (-3.09%)

News & Announcements

Price vs Volume

Stock Trivia

Unichem Laboratories Ltd NSE / BSE
Pharmaceuticals, Mid Cap

213.45

-6.80 (-3.09%)